Onco-Inmunología Aplicada y Traslacional
O-I Traslacional
Ana
Patiño García
Consultora Investigadora
Publicaciones en las que colabora con Ana Patiño García (11)
2024
2021
-
Whole exome sequencing characterization of individuals presenting extreme phenotypes of high and low risk of developing tobacco-induced lung adenocarcinoma
Translational Lung Cancer Research, Vol. 10, Núm. 3, pp. 1327-1337
2020
-
Performance comparison of two next-generation sequencing panels to detect actionable mutations in cell-free DNA in cancer patients
Clinical Chemistry and Laboratory Medicine, Vol. 58, Núm. 8, pp. 1341-1348
2019
-
Designing clinical studies for biomarker discovery: The design criteria
Proteomic and Metabolomic Approaches to Biomarker Discovery (Elsevier), pp. 441-466
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
-
The dynamic use of EGFR mutation analysis in cell-free DNA as a follow-up biomarker during different treatment lines in non-small-cell lung cancer patients
Disease Markers, Vol. 2019
2018
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
Liquid Biopsy: From Basic Research to Clinical Practice
Advances in Clinical Chemistry (Academic Press Inc.), pp. 73-119
-
Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma
Lung Cancer, Vol. 122, pp. 120-123
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2016
-
Total and mutated EGFR quantification in cell-free DNA from non-small cell lung cancer patients detects tumor heterogeneity and presents prognostic value
Tumor Biology, Vol. 37, Núm. 10, pp. 13687-13694